Compare ARK Genomic Revolution ETF (ARKG) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.19, while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.9. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SJNK | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $25.63 |
52-Week Low | $23.09 | $24.75 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SJNK, the SPDR Bloomberg Short Term High Yield Bond ETF, trades at $24.91, down slightly by 0.08% over 24 hours. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators are neutral. The ETF maintains a consistent dividend payout schedule, with recent distributions of $0.14 and $0.15 per share. Recent news highlights institutional interest, with Berkshire Money Management increasing its stake by 3.0% as of the latest SEC filing in April 2026.
The outlook for SJNK is clouded by bearish technicals and cautious analyst sentiment, with some sources rating it a SELL due to exhausted tailwinds from falling yields. Key risks include high sensitivity to interest rate changes and credit spread volatility. However, its monthly dividend history since 2012 and institutional accumulation may appeal to income-focused investors willing to navigate short-term market fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
